OraSure Appoints Anne Messing as Chief Commercial Officer to Drive Growth and Sales Excellence

OraSure Technologies has appointed Anne Messing as its Chief Commercial Officer. Messing brings over 25 years of healthcare industry experience, with a focus on driving growth and sales excellence. She will oversee Sales, Marketing, Strategic Alliances, and Product Management at OraSure. Her appointment is expected to drive the company towards its strategic goals, including upcoming product launches.

OraSure Technologies, Inc. (OTI) has appointed Anne Messing as its Chief Commercial Officer, effective immediately. Messing brings over 25 years of commercial leadership experience in the healthcare industry, including roles at Becton Dickinson (BD) Biosciences and Danaher. Her appointment aims to drive the company towards its strategic goals, including upcoming product launches.

Messing will oversee Sales, Marketing, Strategic Alliances, and Product Management at OTI. She has a proven track record of driving growth and building high-performing sales teams. Prior to joining OTI, she was Vice President and General Manager of the U.S. Region for BD Biosciences, where she spearheaded initiatives that outperformed market benchmarks and generated meaningful sales growth [1].

Carrie Eglinton Manner, President and CEO of OTI, expressed her confidence in Messing's ability to create exceptional value for stakeholders. "We are delighted to welcome Anne as our Chief Commercial Officer," Manner said. "Her deep expertise, motivational leadership, and proven success in delivering results will be instrumental in driving the organization forward as we continue to execute our mission to improve access, quality, and value in healthcare through innovative solutions in effortless testing and sample management."

Messing is excited about the opportunity to lead OTI and contribute to its vision for the future. "I’m excited to step into this transformative chapter with OTI, as the company accelerates its vision for the future and prepares for a wave of impactful and strategic product launches," she said.

OraSure Technologies is expected to report a decrease in quarterly revenue when it releases results on August 5 for the period ending June 30, 2025. Analysts expect a 44.1% decrease in revenue to $30.358 million from $54.34 million a year ago [2]. The company's guidance for the period was for revenue between $28.50 million and $32.50 million.

References:
[1] https://www.morningstar.com/news/globe-newswire/9504708/orasure-appoints-anne-messing-as-chief-commercial-officer
[2] https://www.tradingview.com/news/reuters.com,2025:newsml_L8N3TT2VS:0-orasure-technologies-inc-expected-to-post-a-loss-of-20-cents-a-share-earnings-preview/